Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Amanda Heppell-Parton is active.

Publication


Featured researches published by Amanda Heppell-Parton.


Nature Genetics | 1995

A site–directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination

Andrew Smith; Michelle A. De Sousa; Bernard Kwabi-Addo; Amanda Heppell-Parton; Helen Impey; Pamela Rabbitts

We have developed a strategy for chromosome engineering in embryonic stem (ES) cells that relies on sequential gene targeting and Cre–loxP site–specific recombination. Gene targeting was first used to integrate loxP sites at the desired positions in the genome. Transient expression of Cre recombinase was then used to mediate the chromosomal rearrangement. A genetic selection relying on reconstruction of a selectable marker from sequences co–integrated with the loxP sites allowed detection of cells containing the Cre–mediated rearrangement. A programmed translocation between the c–myc and immunoglobulin heavy chain genes on chromosomes 15 and 12 was created by this method. This strategy will allow the design of a variety of chromosome rearrangements that can be selected and verified in ES cells or activated in ES cell–derived mice.


Oncogene | 1998

Homozygous deletions at 3p12 in breast and lung cancer

Vasi Sundaresan; Grace Chung; Amanda Heppell-Parton; J Xiong; Catherine Grundy; Ian Roberts; Louise A James; Anthony Cahn; Anthony Bench; Jenny Douglas; John D. Minna; Yoshitaka Sekido; Michael I. Lerman; Farida Latif; Jonas Bergh; Hua Li; Nick Lowe; Donald J. Ogilvie; Pamela Rabbitts

We have constructed a physical map of the region homozygously deleted in the U2020 cell line at 3p12, including the location of putative CpG islands. Adjacent to one of these islands, we have identified and cloned a new gene (DUTT1) and used probes from this gene to detect two other homozygous deletions occurring in lung and breast carcinomas: the smallest deletion is within the gene itself and would result in a truncated protein. The DUTT1 gene is a member of the neural cell adhesion molecule family, although its widespread expression suggests it plays a less specialized role compared to other members of the family.


Genomics | 1995

Thioredoxin, a mediator of growth inhibition, maps to 9q31

Amanda Heppell-Parton; Anthony Cahn; Anthony J. Bench; Nicholas Lowe; Hans Lehrach; Günther Zehetner; Pamela Rabbitts

The human thioredoxin gene has been provisionally mapped to 3p11-p12. Recently thioredoxin cDNA has been isolated in a procedure that detects transcripts coding for growth-suppressing proteins, and thus the chromosomal location of the gene is of particular interest. Chromosome 3 is believed to harbor several tumor suppressor genes important in the development of lung and other common epithelial tumors. To establish more firmly the chromosomal location of the human thioredoxin gene, a somatic hybrid panel was used; it identified chromosome 9 as the location of the transcribed thioredoxin gene. Fluorescence in situ hybridization of a YAC encoding the transcribed thioredoxin gene refined the localization to 9q31.


Cancer Genetics and Cytogenetics | 1999

A Combined Approach of Conventional and Molecular Cytogenetics for Detailed Karyotypic Analysis of the Small Cell Lung Carcinoma Cell Line U2020

Amanda Heppell-Parton; Elizabeth P. Nacheva; Nigel P. Carter; Pamela Rabbitts

Until recently the ability to analyze complex karyotypic rearrangements was totally dependent upon light microscopy of G-banded chromosomes. Developments in the area of molecular cytogenetics have revolutionized such analysis, making it possible to determine the nature of complex rearrangements. An extensive analysis has been made of the small cell lung carcinoma (SCLC) cell line U2020, using a combined approach of conventional and molecular cytogenetics, enabling a highly detailed karyotype to be constructed revealing rearrangements previously undetected by G-banding alone. This approach offers the opportunity to reassess other tumor karyotypes, particularly those of high complexity found in solid tumors, for tumor-specific consistent rearrangements indecipherable by conventional karyotyping.


Cytogenetic and Genome Research | 1994

Multicolour fluorescence in situ hybridisation to order small, single-copy probes on metaphase chromosomes

Amanda Heppell-Parton; D.G. Albertson; R. Fishpool; P.H. Rabbitts

In constructing complete human chromosome maps, the relative order of markers and their precise chromosomal location will be combined. Multicolour in situ hybridisation, in which two probes are simultaneously hybridised to chromosomes and subsequently distinguished, potentially will provide both types of information. Using this technique, we have produced an ordered map of eight human chromosome 3 DNA markers, using small, single-copy probes that can detect target sequences ranging in size from 4 kb to as little as 500 bp.


Cancer Genetics and Cytogenetics | 1999

Elucidation of the Mechanism of Homozygous Deletion of 3p12∼13 in the U2020 Cell Line Reveals the Unexpected Involvement of Other Chromosomes

Amanda Heppell-Parton; Elizabeth P. Nacheva; Nigel P. Carter; Jonas Bergh; Donald J. Ogilvie; Pamela Rabbitts

Homozygous deletions in tumor cells have been useful in the localization and validation of tumor suppressor genes. We have described a homozygous deletion in a lung cancer cell line (U2020) which is located within the most proximal of the three regions on the short arm of chromosome 3 believed to be lost in lung cancer development. Construction of a YAC contig map indicates that the deletion spans around 8 Mb, but no large deletion was apparent on conventional cytogenetic analysis of the cell line. To investigate this paradox, whole chromosome, arm-specific, and regional paints have been used. This analysis has revealed that genetic loss has occurred by complex rearrangements of chromosomes 3, rather than simple interstitial deletion. These studies emphasize the power of molecular cytogenetics to disclose unsuspected tumor-specific translocations within the extremely complex karyotypes characteristic of solid tumors.


Human Genetics | 1992

Molecular and genetic characterization and physical mapping of 11 new markers detecting multiallele restriction fragment length polymorphisms on the short arm of human chromosome 3

Farida Latif; William S. Modi; Fuh-Mei Duh; Laura S. Schmidt; Hua Li; L. Geil; Mary Lou Orcutt; Amanda Heppell-Parton; Pamela Rabbitts; W. Marston Linehan; Berton Zbar; Michael I. Lerman

SummaryGenetic markers with high degrees of polymorphisms are of vital importance in the construction of high resolution (2–4 cM) linkage maps of human chromosomes as specified in the short-term goals of the Human Genome Initiative. In this paper, we report on molecular and genetic characterization and physical localization of 11 new multiallele restriction fragment length polymorphism markers on human chromosome 3p. Ten of these represent three- and four-allele polymorphisms of the base substitution type probably at two adjacent restriction sites. One has been identified as a novel minisatellite sequence comprising a variable copy number tandem repeat array of a G/T-rich 79-bp sequence. This collection of multiallele polymorphic (PIC values: 0.40–0.60) markers should prove valuable and increase the resolution power of the available chromosome 3p genetic markers.


Nature Genetics | 1995

Chromosome specific paints from a high resolution flow karyotype of the mouse

Pamela Rabbitts; Helen Impey; Amanda Heppell-Parton; Cordelia Langford; Charles Tease; Nicholas Lowe; David M. D. Bailey; Malcolm A. Ferguson-Smith; Nigel P. Carter


Journal of the National Cancer Institute | 1994

A 190-Kilodalton Protein Overexpressed in Non-P-Glycoprotein-Containing Multidrug-Resistant Cells and Its Relationship to the MRP Gene

Margery A. Barrand; Amanda Heppell-Parton; Karen A. Wright; Pamela Rabbitts; Peter R. Twentyman


Genes, Chromosomes and Cancer | 1992

Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: A strategy for cloning the putative tumor suppressor gene

Farida Latif; Kalman Tory; William S. Modi; Stephen L. Graziano; Gary P. Gamble; Jenny Douglas; Amanda Heppell-Parton; Pamela Rabbitts; Berton Zbar; Michael I. Lerman

Collaboration


Dive into the Amanda Heppell-Parton's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Helen Impey

Laboratory of Molecular Biology

View shared research outputs
Top Co-Authors

Avatar

Nigel P. Carter

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Michael I. Lerman

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Andrew Smith

University of Edinburgh

View shared research outputs
Top Co-Authors

Avatar

Anthony Cahn

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Farida Latif

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar

Jenny Douglas

The Royal Marsden NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge